Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Condition: Obesity Interventions: Drug: XW003; Drug: Saxenda Sponsors: Sciwind Biosciences APAC CO Pty. Ltd.; Hangzhou Sciwind Biosciences Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2021 Category: Research Source Type: clinical trials